Table 3_Comprehensive genomics, systems, and structural assessment for novel target identi

665 PRSP genomes from Indian clinical isolates collected between 1996 and 2022 were analyzed. The dataset likely contains results from an integrated in silico strategy including pangenome construction, GWAS, and structural modeling. It was authored by Avani Panickar and last updated on 2026-04-29.

Use Cases

• Identifying gene clusters associated with penicillin resistance based on GWAS results.
• Prioritizing candidate drug targets based on essentiality screening and druggability assessment.
• Analyzing evolutionary conservation of potential targets across the PRSP population.
• Evaluating structural models and binding pockets for identified proteins like OppC2.

Strengths

• Includes 665 high-quality genome assemblies from a defined time range (1996-2022).
• Results are derived from a multi-method approach integrating genomics, GWAS, network analysis, and simulations.
• Data is openly licensed under CC-BY-4.0.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (30.3 KB), suggesting it contains summary or processed results rather than raw genomic data.

Provenance

Source

figshare

Collection Method

In silico analysis of genome assemblies from clinical isolates.

Time Range

1996-2022

Freshness

Last updated 2026-04-29 05:54:27; freshness should be verified.

Geography

India